Baxter International (FRA:BTL) YoY EBITDA Growth : 7.89% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Baxter International YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Baxter International's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 7.89%.

Baxter International's EBITDA per Share for the three months ended in Dec. 2023 was €1.23.

Baxter International YoY EBITDA Growth Historical Data

The historical data trend for Baxter International's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baxter International YoY EBITDA Growth Chart

Baxter International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-18.80

11.19

5.80

-141.97

289.26

Baxter International Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															191.82	-5.18	-61.39	109.69	7.89

Baxter International YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Baxter International's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(3.03	-	-1.601)	/	\| -1.601 \|
=	289.26 %

Baxter International's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(1.231	-	1.141)	/	\| 1.141 \|
=	7.89 %

Baxter International YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Baxter International's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Baxter International (FRA:BTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baxter International Inc (FRA:BTL) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

BAX:USA 1BAX:Italy BAX:Austria

Address

One Baxter Parkway, Deerfield, IL, USA, 60015

Website

https://www.baxter.com

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.

Baxter International (FRA:BTL) Headlines

No Headlines